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A cardinal feature of adaptive, cytotoxicT lymphocyte (CTL)-mediated immunity is the ability
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INTRODUCTION
A cardinal feature of adaptive, cytotoxic T lymphocyte (CTL)-
mediated immunity is the ability of naïve CTLs to undergo
a program of differentiation and proliferation upon activation
resulting in the acquisition of lineage-speciﬁc T cell functions and
eventual establishment of immunological memory (Kaech et al.,
2002a; van Stipdonk et al., 2003). CTLs contribute to the control
and eventual elimination of a myriad of pathogen (intracellular
bacteria and viruses) and tumor challenges via the coordinated
interplay of varied effector mechanisms that include; (1) the pro-
duction of pro-inﬂammatory cytokines such as interferon (IFN)-γ
and tumor necrosis factor (TNF)-α (La Gruta et al., 2004); and
(2) the expression of cytolytic effector molecules including per-
forin (Pfp; Kagi et al., 1994) and the granule enzymes (granzymes,
Gzm) A, B, and K (Jenkins et al., 2007; Peixoto et al., 2007; Moffat
et al., 2009). Once infection is cleared, the expanded effector T
cell population contracts with establishment of a pool of long-
lived, pathogen-speciﬁc memory T cells (Marshall et al., 2001;
Kaech et al., 2002b; La Gruta et al., 2004). Although quiescent,
memory CTLs demonstrate rapid effector function without the
need for further differentiation (Lalvani et al., 1997; Oehen and
Brduscha-Riem, 1998; Cho et al., 1999; Veiga-Fernandes et al.,
2000). The combination of a high frequency and rapid effector
function enables memory CTLs to respond more rapidly upon
secondary infection, enabling earlier control and clearance of
infection. Importantly, our understanding of the factors that not
only shape the cell fate decisions to be a memory versus effector
T cells are unclear, but the molecular mechanisms that enable sta-
ble maintenance of rapid effector function in the long-term are
also not well understood. This review will examine new advances
in our understanding of the molecular mechanisms that control
effector and memory CD8+ T cell differentiation.
INITIATION OF T CELL RESPONSES
Initiation of naïve CTL activation requires recognition of pMHC
complexes on a specialized subset of antigen-presenting cells,
termed dendritic cells (DCs). DCs exist as two general popu-
lations – tissue-resident and lymph node-resident DCs (Heath
and Carbone, 2001). Importantly, in the context of periph-
eral infections such as respiratory inﬂuenza A virus infection
and herpes simplex virus infection of the skin, both tissue-
resident and lymph node-resident DCs appear to play roles
in the induction of T cell immunity (Allan et al., 2003; Belz
et al., 2004; Heath and Carbone, 2009). A primary role for
tissue-resident DCs is continual surveillance of their environ-
ment for the presence of invading pathogens. Upon infection,
tissue-resident DCs are activated via pathogen pattern recep-
tors, such as Toll-like receptors or intracellular sensors such
as RIG-I, MDA-5, and members of the inﬂammasome com-
plex, resulting in activation and trafﬁcking of these DCs from
the tissues to the draining lymph node. The activation of DCs
also results in the concomitant up-regulation of co-stimulatory
molecules, such as CD80/CD86. Thus, these migratory DCs
not only carry antigen from the infected tissue to the draining
lymph node, but are now capable of providing the necessary
secondary signals to promote activation of naïve and mem-
ory antigen-speciﬁc T cells (Heath and Carbone, 2001; Belz
et al., 2007). A third signal, provided via signaling induced
by pro-inﬂammatory cytokines such as type I IFNs and inter-
leukin (IL)-12, is also required for full priming of mature
effector T cell responses (Curtsinger et al., 2003a,b). Thus the
integration of multiple signals received via the T cell receptor,
co-stimulation and inﬂammatory cytokine receptors is required
to drive differentiation of naïve T cells to effector and memory
cells.
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THE EFFECTOR PHASE: ACQUISITION OF CTL EFFECTOR
FUNCTION
As little as 2 h of in vitro peptide stimulation is sufﬁcient to initiate
an autonomous program of T cell proliferation and differentiation
(Kaech and Ahmed, 2001; van Stipdonk et al., 2003). These initial
observations were supported by in vivo studies demonstrating that
early termination of antigen-presentation did not overly impact
effector and memory CTL differentiation after infection (Wong
and Pamer, 2001, 2003; Prlic et al., 2006). Thus, it would appear
that naïve CD8+ T cells are pre-programed for differentiation
prior to any antigen exposure. This concept is aligned with the
recent data demonstrating that dynamic changes in genomic and
transcriptional programing occurring during T cell development
are key for establishing a genetic blueprint that likely underpins
the fate of naïve T cells after activation (Zhang et al., 2012).
Progressive differentiation is a key factor that shapes both
the phenotypic and functional heterogeneity of pathogen-speciﬁc
CTL responses (Marzo et al., 2005; Badovinac et al., 2007). The
acquisition of IFN-γ (Lawrence and Braciale, 2004), Pfp (Jenkins
et al., 2008), and granzyme expression (Oehen and Brduscha-
Riem, 1998; Jenkins et al., 2008; Moffat et al., 2009) is clearly linked
to ongoing lymphocyte proliferation (Badovinac et al., 2007; Jenk-
ins et al., 2008). In addition, functional proﬁling of effector and
memory CTL induced after primary inﬂuenza A virus infection of
C57BL/6Jmice demonstrated that proﬁles of intracellular cytokine
expression (both mRNA and induced protein) followed a strict
hierarchy and most likely reﬂected sequential acquisition of mul-
tiple effector functions due to progressive differentiation following
activation (La Gruta et al., 2004).
In terms of cytokine production, recent observations suggest
that polyfunctional potential (TNF-α+IFN-γ+) is acquiredwithin
three to four divisionswith acquisition of IFN-γ production (Den-
ton et al., 2011). However, extended cycling leads to the loss of
TNF-α production for a substantial set of activated CTLs lead-
ing to a progressive diminution in polyfunctional capacity. This
is supported by the observation that activation of TCR transgenic
T cells with “low afﬁnity” ligands leads to an inability to sustain
extended proliferation with these less differentiation CTL exhibit-
ing co-expression of IFN-γ and TNF-α (Zehn et al., 2009). This
contrasts with acquisition of cytolytic gene expression (Pfp and
the granzymes) where continued cell division leads to a broader
spectrum of effector gene expression (Jenkins et al., 2007, 2008;
Peixoto et al., 2007). Recent data also suggests that there is a hier-
archy of expressionwith granzymeB acquired early after activation
with extended proliferation required for both GzmA and GzmK
expression (Jenkins et al., 2008; Moffat et al., 2009; Zehn et al.,
2009). Differences in the temporal expression of regulatory fac-
tors required for Gzm and cytokine gene loci likely explains these
differences.
THE MEMORY PHASE
Memory T cells can be broadly divided into “central” and “effec-
tor” memory subsets, with the two differing in both phenotypic
and functional characteristics that reﬂect the different roles they
play in response to secondary infection (Sallusto et al., 1999, 2004).
Effector memory T cells (or TEM) typically express tissue-speciﬁc
homing markers such as CCR5, CXCR3, and integrins and while
they can be found in the circulation, signiﬁcant numbers are
found in the non-lymphoid tissues (Masopust et al., 2001). More-
over, TEM are associated with decreased proliferative capacity and
immediate effector function, such as cytotoxicity in the case of CTL
(Masopust et al., 2001). While TEM are capable of entering non-
lymphoid tissues from the circulation in the steady state (Wakim
et al., 2008; Kohlmeier et al., 2011), recent reports have identiﬁed
tissue-resident TEM that persist in the long-term at the original
site of infection (Gebhardt et al., 2009, 2011; Mackay et al., 2012).
Central memory T cells (TCM) typically express the lymph
node homing markers, CD62L (L-selectin) and CCR7, and exhibit
greater proliferative capacity when compared to TEM (Masopust
et al., 2001). The fact that TCM localize to lymph nodes in greater
numbers and are capable of proliferation in response to sec-
ondary infection ensures greater numbers of effector CTL are
generated earlier. Thus, TCM provide a more rapid response and
provide a second wave of effector CTL capable of clearing any
remaining active infection that TEM have failed to control (Wherry
et al., 2003).
Just when after infection memory T cells are generated is the
basis of some conjecture. However, there is strong evidence that T
cell memory can be established very early after infection, especially
when inﬂammation is limiting. For example, the prophylactic use
of antibiotics prior to Listeria monocytogenes infection, or vac-
cination with peptide pulsed DCs, demonstrated that functional
memory T cells can be generated as soon as 4–6 days after prim-
ing (Badovinac et al., 2005). This is supported by a study where
it was shown that T cells isolated from IAV infected mice as early
as 3–4 days after infection could form memory when adoptively
transferred into a second host (Kedzierska et al., 2006, 2007).
Recent studies have suggested that effector ormemoryTcell fate
can be predicted during the primary effector phase based on the
cell surface expression of both the killer cell lectin-like receptor
G1 (KLRG1) and IL-7 receptor subunit-α (IL-7Rα; Kaech et al.,
2003; Joshi et al., 2007). Activated T cells that express high lev-
els of KLRG1 and low levels of IL-7Rα (KLRG1hiIL-7Rαlo) are
largely destined to be terminally differentiated effector cells and
are termed short-lived effector cells (SLECs). In contrast, the
small population of activated T cells that are KLRG1loIL-7Rαhi
demonstrate memory potential and are termed memory precur-
sor effector cells (MPECs). While the models of effector versus
memory T cell fate are still an area of debate (reviewed by Kaech
and Cui, 2012), recent advances have started to provide insights
into the molecular factors that shape the outcomes of T cell
activation.
MOLECULAR FACTORS THAT SHAPE ACQUISITION OF
EFFECTOR FUNCTION
Speciﬁc transcription factors determine T cell effector and mem-
ory function and fate (Intlekofer et al., 2005; Joshi et al., 2007;
Cruz-Guilloty et al., 2009; Kallies et al., 2009; Pipkin et al., 2010;
Zhang et al., 2010; Figure 1). In the case of CTL effector func-
tion three transcription factors appear to play “pioneering” roles
in determining effector T cell differentiation. Two T-box tran-
scription factors, Tbx21 (T-bet) and Eomesodermin (Eomes;
Intlekofer et al., 2005) play essential roles in effector CTL differen-
tiation.While T-bet is normally associatedwithCD4+ TH1 lineage
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FIGURE 1 |Transcription factor regulation of effector and memory
T cell differentiation. Shown are transcription factors that are expressed
and act to promote either effector CTL (red lines) or memory CTL
(blue lines) differentiation at the different stages after infection including
the priming phase (green), differentiation stage (orange) or once the
cell fate has been determined (purple shading). Adapted from Pipkin
and Rao, Cell, Snapshots Archive, Effector and memory
T cells.
commitment, in part, by promoting expression of IFN-γ (Szabo
et al., 2000), it is also rapidly up-regulated in activated CTL, con-
tributing to rapid acquisition of IFN-γ production and helping
promote GzmB expression (Cruz-Guilloty et al., 2009). Eomes, a
homolog of T-bet, was originally implicated in the regulation of
CD8+ T cell GzmB expression (Pearce et al., 2003), however recent
studies suggest that Eomes is expressed later during CTL differ-
entiation and contributes more to acquisition of Pfp expression
and maintenance of the capacity to express IFN-γ (Cruz-Guilloty
et al., 2009). The fact that Eomes over-expression does not rescue
diminished GzmB expression in T-bet-deﬁcient CTL suggests that
the contribution of Eomes in determining speciﬁc T cell func-
tion is highly dependent on the timing and extent of expression
(Cruz-Guilloty et al., 2009).
It is becoming clear that various transcription factors work
cooperatively to reinforce the commitment of naïve T cells to
become fully differentiated effector T cells. For example, the
runt-related transcription factor 3 (Runx3), expressed by naïve
CTLs, promotes expression of a variety of signature CTL effec-
tor molecules such as IFN-γ, GzmB, and Pfp (Cruz-Guilloty et al.,
2009). Runx3 appears to have both a direct affect via binding to
promoter and regulatory regions within the Ifn-γ, gzmB, and pfp
gene loci. Moreover, Runx3 also promotes Eomes transcription
further promoting CTL differentiation and acquisition of effector
function (Cruz-Guilloty et al., 2009). Given that Runx3 is con-
stitutively expressed in naïve T cells, just what regulates Runx3
activity is not clear. However, upon T cell activation Runx3 can
bind to IL-2 responsive regulatory elements within the pfp gene
locus (Cruz-Guilloty et al., 2009). Thus it is likely that IL-2 signals
received upon CTL activation are required for Runx3 activity on a
subset of effector gene loci.
Interleukin-2 is a key cytokine required for inducing prolif-
eration and survival of activated T cells (Miyazaki et al., 1995).
Importantly, high levels of IL-2 signaling at the time of CTL
activation also contribute to signature effector gene expression,
including expression of GzmB and Pfp (Janas et al., 2005; Pipkin
et al., 2010). IL-2-dependent regulation of effector CTL differenti-
ation is primarily via IL-2Rβ signaling and subsequent activation
of STAT5. This results in binding of activated STAT5 to the GzmB
promoter, thus helping promote gene transcription. In contrast,
up-regulation of Pfp expression ﬁrst requires STAT5 to bind to
regulatory elements within the Eomes promoter with subsequent
Eomes expression able to promote Pfp expression (Cruz-Guilloty
et al., 2009). This IL-2-STAT5 pathway also likely explains the IL-
2 dependency of Runx3 promotion of effector gene expression
(Cruz-Guilloty et al., 2009).
Another key transcription factor in CTL effector differentia-
tion is the B lymphocyte-induce maturation protein-1 (Blimp-1)
encoded by Prdm1. A role for Blimp-1 in lymphocyte differenti-
ation was ﬁrst observed in activated B cells where it is required
for the terminal differentiation and subsequent maintenance of
long-lived antibody-secreting cells (Shapiro-Shelef et al., 2003).
Recent studies have demonstrated that Blimp-1-deﬁcient T cells
are unable to fully differentiate into effector CTL in response to
virus infection. Rather, Blimp-1-deﬁcient CTL preferentially dif-
ferentiate into effectorCTL that have“memory like”characteristics
such ashigh levels of IL-7α andBcl6 expression (see below) and low
levels of typical effectormarkers such asKLRG1andGzmB(Kallies
et al., 2009; Rutishauser et al., 2009). Thus, Blimp-1 appears to
ensure that activated lymphocytes, including CTL, become ter-
minally differentiated effectors. Importantly, the same high IL-2
activating conditions that contribute to CTL effector gene expres-
sion, also contribute to up-regulation of Blimp-1 and repression
of the transcription factor Bcl6 and IL-7Rα expression (Pipkin
et al., 2010). This transcriptional proﬁle is a hallmark of terminal
CTL differentiation (Kaech et al., 2002b) and hence IL-2 not only
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contributes to acquisition of effector function but also to effector
CTL differentiation.
So what signals dictate the decision for activated CTL to dif-
ferentiate toward either an effector or memory T cell fate? A
major driver appears to the response of activated CTL to pro-
inﬂammatory mediators produced upon infection. For example,
T-bet up-regulation in activated CTLs is clearly induced via TCR
ligation and inﬂammatory mediators such as IL-12 and IFN-γ
(Mullen et al., 2001; Szabo et al., 2002; Sullivan et al., 2003; Take-
moto et al., 2006), and results in differentiation of effector T cells.
Moreover, IL-12 signaling serves to both simultaneously promote
and suppresses T-bet and Eomes expression, respectively (Take-
moto et al., 2006). Thus, the degree of inﬂammatory stimulation
serves to establish higher levels of T-bet and tips the balance toward
effector CTL differentiation (Joshi et al., 2007).
REGULATING THE T-bet/Eomes NEXUS AND MEMORY
T CELL FATE
Current evidences suggest that the programing of T cell mem-
ory occurs early during the priming phase (Feau et al., 2011).
Thus, what precisely are the factors that translate signals received
during priming into this memory capacity? While initially con-
sidered a key driver of signature CTL effector gene expression,
and hence effector differentiation, it has recently emerged that
Eomes may play a more prominent role in memory T cell for-
mation and persistence (Intlekofer et al., 2005; Banerjee et al.,
2010). This in part likely due to Eomes-dependent up-regulation
of the IL-2β receptor (CD122), enabling responsiveness to IL-15,
a cytokine needed for maintenance of memory T cells (Intlekofer
et al., 2005).
As described earlier, induction of high levels of T-bet expres-
sion in response to pro-inﬂammatory cytokines serves to promote
effector T cell differentiation. Thus, it is interesting that T-bet deﬁ-
ciency within virus-speciﬁc CTL results in fewer TCM (Intlekofer
et al., 2007). Thus, T-bet appears to not only promote effector T
cell differentiation, but to actively suppress memory T cell for-
mation. Just how T-bet does this is not clear but is tempting to
speculate that it may act as a transcriptional repressor inhibiting
expression of gene loci required for memory T cell programing.
This will be a key area of research in the future.
The importance of regulating the T-bet/Eomes nexus in deter-
mining effector versus memory T cell fate is highlighted by the fact
that a number of extrinsic signaling pathways serve to regulate the
balance of T-bet and Eomes levels in activated T cells. Expres-
sion of the transcription factor Foxo1 actively represses effector
differentiation by blocking T-bet expression, while at the same
time promoting Eomes expression and maintenance of memory
T cell generation (Rao et al., 2012). Activation of the mammalian
target of rapamycin (mTOR) kinase inactivates Foxo1 function
thereby releasing T-bet from Foxo1 inhibition and thus, pro-
moting effector CTL differentiation (Rao et al., 2012). Therefore,
the use of rapamycin, or some other inhibitor of mTOR activ-
ity may be a useful intervention that promotes memory T cell
generation.
Another member of the fork head family of transcription fac-
tors, Foxo3a, has also been implicated in the regulation of effector
versus memory T cell fate (Riou et al., 2007; van Grevenynghe
et al., 2008). Comparison of transcriptional signatures between
polyclonal human CD4+ TCM and TEM demonstrated differential
expression of genes regulated by Foxo3a (Riou et al., 2007), includ-
ing Bim. Phosphorylation results in the exclusion of Foxo3a from
the nucleus and subsequent transcriptional inactivation (Brunet
et al., 1999), thus it was of interest that TCM had higher levels
of phosphorylated Foxo3a compared to TEM. Importantly, it was
determined that both TCR and signals via the common γ-chain
cytokine receptor induce Foxo3a phosphorylation and subsequent
protection from Bim-mediated apoptosis. Hence, this provides a
molecular mechanism for how homeostatic signals regulate mem-
ory T cell persistence (Riou et al., 2007). Moreover, inhibition of
Foxo3a expression has been shown to prolong human immun-
odeﬁciency virus-speciﬁc memory T cell survival, indicating that
Foxo3a is a potential target for therapeutic intervention that could
promote memory T cell establishment (Riou et al., 2007; van
Grevenynghe et al., 2008).
In another example of extrinsic signals promoting memory
T cell differentiation, activation of the Wnt-β-catenin signal-
ing pathway has been shown to promote expression of the
transcription factor T cell factor-1 (TCF-1), with subsequent
up-regulation of Eomes (Zhou et al., 2010). As observed in Eomes-
deﬁcient mice (Banerjee et al., 2010), TCF-1-deﬁcient mice fail
maintain a CD62Lhi TCM population after challenge, supporting
the notion that programing of memory CTL requires expres-
sion of TCF-1 that in-turn promotes Eomes expression (Zhou
et al., 2010).
THE ROLE OF OTHER TRANSCRIPTIONAL REGULATORS IN
MEMORY T CELL DIFFERENTIATION
Given that inﬂammation is a key driver of effector T cell differen-
tiation, a question that arises is how does memory arise in the face
of a robust infection? Recent evidence suggests that environmental
cues may serve to limit the impact of inﬂammatory-driven effec-
tor T cell differentiation allowing for memory T cell formation
early after infection. Both IL-10 and IL-21 have been reported to
promote memory T cell differentiation (Yi et al., 2010). Further,
it has been recently demonstrated that after LCMV infection, sig-
naling via STAT3, a transcription factor necessary for transmitting
IL-10R and IL-21R signals, is necessary for memory CTL for-
mation (Cui et al., 2011). Signiﬁcantly, STAT3-dependent signals
promote the expression of the transcription factor BCL6, known
to be up-regulated within memory CTL while at the same time,
repressing Blimp-1 expression. Moreover, STAT3-deﬁcient CTL
had lower levels of suppressor of cytokine signaling-3 (SOCS-3)
expression and were more responsive to IL-12-dependent differ-
entiation (Cui et al., 2011). Thus, signaling via immune regulatory
cytokines, such as IL-10 and/or IL-21, can promote memory
T cell differentiation by both up-regulating key memory T cell
fate governing genes, while at the same time actively limiting
the impact of inﬂammatory signals and subsequent effector CTL
differentiation.
Finally, the inhibitor of DNA binding (Id)-2, and Id3 proteins
have opposing roles in determining effector versus memory CTL
generation. While pathogen-speciﬁc CTL within Id2-deﬁcient
mice could respond and differentiate into effectors, they exhib-
ited a diminished response magnitude after infection and delayed
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pathogen clearance (Cannarile et al., 2006; Yang et al., 2011).
Importantly, therewas a failure to establish aTEM populationupon
clearance of infection. These data suggest that Id2 up-regulation
is required for sustained effector differentiation and establish-
ment of the TEM repertoire. Moreover, STAT5 and STAT4 binding
sites have been identiﬁed within the Id2 promoter suggesting that
the inﬂammatory signals known to drive effector differentiation,
such as IL-2 and IL-12, can act on Id2 to promote this fate (Yang
et al., 2011).
In contrast to Id2, Id3 is down-regulated upon CTL activa-
tion but is then re-expressed by memory T cells (Yang et al.,
2011). Interestingly, while effector differentiation is normal in Id3-
deﬁcient mice, there is a failure to maintain a long-lived memory T
cell population upon clearance of infection (Ji et al., 2011). Thus,
Id3 expression is a key checkpoint that contributes to establish-
ment of a robust memory T cell population. In fact, up-regulation
of Blimp-1 has been shown to inhibit Id3 expression, representing
a key switch in effector versus memory T cell fate determination
(Ji et al., 2011; Yang et al., 2011).
In summary, a complex transcriptional network interprets and
integrates the various extrinsic signals received by an activated T
cell soon after infection. While there is signiﬁcant understand-
ing about the precise role these transcriptional networks have in T
cell differentiation, little is known about regulation of the genomic
template they bind and how changes in the biochemical and struc-
tural composition of the genome regulates this activity. The next
section of this review will examine the role of epigenetics, or mod-
iﬁcations of chromatin, in regulating effector and memory T cell
differentiation.
EPIGENETIC REGULATION: THE ROLE OF HISTONE
MODIFICATIONS
Within eukaryotic cells, genomic DNA is wrapped around a
complex of histone proteins that organize to form a structure
termed chromatin (Figure 2). The basic unit of chromatin is
the nucleosome, where DNA is wrapped around an octameric
histone complex, typically containing two each of the core his-
tones H2A, H2B, H3, and H4. Importantly, the composition of
chromatin structure and biochemical modiﬁcations of histone
proteins cannot only regulate short-term gene expression patterns
within a cell, but can be propagated as a proliferates ensuring sta-
ble inheritance of a cellular phenotype, a process termed epige-
netics.
Histone modiﬁcations in particular are thought to modulate
gene expression by either changing chromatin structure and/or
by providing a platform that promotes binding of transcrip-
tional regulators (Kouzarides, 2007). Histone proteins can be
modiﬁed by a vast array of covalent modiﬁcations, particularly
on the solvent-exposed N-terminal tail with the combination of
histone PTMs and their genomic location a predictor of tran-
scriptional activity (Table 1; Zhang and Reinberg, 2001; Wang
et al., 2008). For example, acetylation of the histone H3 at lysine
9 (H3K9Ac) that is associated with gene promoters is a positive
correlate of transcriptional activation (Wang et al., 2008). Broadly
speaking, histone acetylation is thought to promote a more open
chromatin structure by masking the overall positive charge of
histones (Aoyagi et al., 2002). This relaxes chromatin structure,
FIGURE 2 | Chromatin structure. Chromatin has two broad structures. The
ﬁrst is euchromatin, characterized by sparse nucleosome density
and is generally associated with active gene transcriptional activity.
Heterochromatin is characterized by high nucleosome density, is very
compacted and is generally associated with repression of gene
transcription. Nucleosomes consist of 147 bp of DNA wound 1.65 turns
around a complex of histone proteins, comprising two each of the H2A,
H2B, H3, and H4 histone variants. Each histone has a soluble amino
terminal tail that can be covalently modiﬁed by speciﬁc epigenetic marks
such as acetylation, methylation, and phosphorylation.
and potentiates transcription factor binding and the recruit-
ment of the core transcription machinery. Conversely, a lack of
histone acetylation restricts chromatin accessibility and can
render theDNA inaccessible to the transcriptionalmachinery (Ura
et al., 1997).
Methylation of histone proteins is somewhat more compli-
cated. For example, tri-methylation of histone 3 at lysine 4
(H3K4me3) is associated with almost all actively transcribed
genes, and has a strong correlation with histone acetylation
and recruitment of RNA polymerase II, indicative of a tran-
scriptionally permissive gene (Bernstein et al., 2002; Santos-Rosa
et al., 2002; Heintzman et al., 2007; Muse et al., 2007). Con-
versely, H3K4 dimethylation can be associated with either active
or repressed genes (Bernstein et al., 2005), suggesting dual roles
for this mark. In contrast to transcriptional activation, deposi-
tion of tri-methylation of H3K27 (H3K27me3) within promoter
regions is strongly linked to transcriptional repression (Wang
et al., 2008). Another repressive mark, H3K9me3, is implicated
in heterochromatin formation through its interaction with hete-
rochromatin protein 1 (HP1; Jacobs and Khorasanizadeh, 2002).
It is becoming increasingly evident that it is the combina-
tion and degree of enrichment of histone modiﬁcations that
is key for ﬁne-tuning gene transcription or silencing (Barski
et al., 2007; Wang et al., 2008). The combination of differ-
ent active and repressive histone modiﬁcations at speciﬁc loci
deﬁnes the transcriptional state of individual genes (Strahl and
Allis, 2000), thus deﬁning cell fate. This is most evident when
considering patterns of H3K4me3 and H3K27me3 within the
same promoter regions. Genome-wide mapping of these two
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Table 1 | Histone modifications and their association with gene
expressiona.
Histone Site Modification Activityb
H2A S1 Phosphorylation −
K5 Acetylation +
K119 Ubiquitylation +/−
H2B K5 Acetylation +
K12 Acetylation +
K15 Acetylation +
K20 Acetylation +
K120 Ubiquitylation +/−
H3 R2 Methylation −
K4 Methylation +
Acetylation +
K9 Methylation −
Acetylation +
S10 Phosphorylation +
K14 Acetylation +
R17 Methylation +
K18 Acetylation +
K23 Acetylation +
K27 Methylation −
Acetylation +
K36 Methylation +/−
K79 Methylation +
H4 R3 Methylation +
K5 Acetylation +
K8 Acetylation +
K12 Acetylation +
K16 Acetylation +
K20 Methylation −
aAdapted fromYi et al. (2010).
bAssociated with activation (+) or repression (−) of genes.
modiﬁcations in embryonic stem cells (ESCs) has demonstrated
that regions important for maintaining ESC pluripotency are
enriched for both H3K4me3 and H3K27me3, termed “biva-
lent” loci (Bernstein et al., 2006; Cui et al., 2009; Hawkins et al.,
2010). Importantly, upon differentiation, the vast majority of
bivalent loci within stem cells resolve to H3K27me3 ensuring
that inappropriate gene expression within speciﬁc cell lineages
does not occur (Bernstein et al., 2006). These data suggest that
bivalency is a switch mechanism by which genes can be rapidly
activated or repressed depending on the differentiation pathway
initiated.
APPROACHES FOR THE ANALYSIS OF HISTONE
MODIFICATIONS WITHIN THE GENOME
A standard approach for examining histone modiﬁcation
within the genome is chromatin immunoprecipitation. Initially,
DNA–protein complexes within nuclei are cross-linked by
formaldehyde ﬁxation, followed by fragmentation of the DNA by
enzymatic digestion or mechanical disruption (i.e., sonication).
The DNA–protein complexes are then immunoprecipitated using
antibodies speciﬁc for either DNA binding proteins (such as tran-
scription factors) or speciﬁc histone covalent modiﬁcations. The
puriﬁed complexes are then treated to reverse the cross-links, and
the DNA isolated and used as a real-time PCR template to inter-
rogate speciﬁc genomic regions of interest. The focused nature of
this approach means that only small genomic regions are probed
in any one reaction (typically 100–300 bp) with extensive analy-
sis of a particular gene locus requiring a laborious and systematic
approach.
The advent of next-generation sequencing technology has rev-
olutionized the study of epigenetic modiﬁcations by enabling
genome-wide proﬁling of chromatin modiﬁcations, an approach
termed ChIP-seq (Kharchenko et al., 2008; Park, 2009). ChIP-seq
involves “deep-sequencing” the immunoprecipitated DNA with
the subsequent short sequences (or reads) being mapped back
onto a reference genome. This approach has yielded an unprece-
dented level of resolution identifying not just the genomic location
of speciﬁc modiﬁcations, but the speciﬁc patterns of enrichment,
as well as their associationwith particular genomic features such as
promoter and enhancers. In combining such data with large-scale
transcriptional proﬁling (i.e., by microarray), our understanding
of how epigenetic modiﬁcations underpin key cellular processes is
undergoing a renaissance.
EPIGENETIC REGULATION OF CD8+ T CELL EFFECTOR
FUNCTION: ACQUISITION AND MAINTENANCE
A deﬁning characteristic of T cell immunity is the acquisition of
lineage-speciﬁc effector function that is readily maintained into
memory. There is a large body of work has determined that spe-
ciﬁc epigenetic mechanisms underpin CD4+ effector T cell lineage
commitment from a naïve state into different effector subsets
(reviewed by Ansel et al., 2003; Kanno et al., 2012). Similarly, there
is a growing body of work that has examined epigenetic regulation
of CD8+ effector T cell differentiation.
Granzyme B expression by activated CD8+, but not CD4+
effector cells, generally reﬂects differences in the lineage-speciﬁc
functions observed for the CD4+ and CD8+ T cell subsets.
Recently we demonstrated that differences in GzmB expression
by in vitro activated CD4+ and CD8+ T cells correlates with dif-
ference in epigenetic modiﬁcations within the gzmB locus (Juelich
et al., 2009). While, CD8+ T cell expression of GzmB was cou-
pled to a signiﬁcant increase in chromatin accessibility, H3K9ac
and H3K4me3 deposition, and docking of RNA polymerase II at
the gzmB promoter region, few of these changes occurred within
activated CD4+ T cells. Strikingly, this study suggests that differ-
ential programing of CD4+ and CD8+ T cell subsets during T
cell development dictates the what lineage-speciﬁc effector func-
tion will be acquired upon activation. In the case of mature, naïve
CD8+ T cells, it ismost likely the combination of transcription fac-
tors including Eomes and Runx3 that direct acquisition of GzmB
expression within activated CD8+, but not CD4+ T cells. It still
remains to be determined whether these lineage-speciﬁc tran-
scription factors play a role in directing the observed epigenetic
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changes during differentiation, or drive effector gene expression
after chromatin remodeling has occurred.
In terms of acquisition and maintenance of CTL-speciﬁc func-
tions recent analysis has demonstrated that dynamic changes in
speciﬁc histone modiﬁcations can underpin observed phenotypic
and functional changes during CD8+ T cell differentiation. It
is under appreciated that naïve T cells can exhibit rapid effec-
tor function upon TCR ligation whereby they rapidly produce
TNF-α, but not IFN-γ prior to initiation of division (Brehm
et al., 2005; Priyadharshini et al., 2010; Denton et al., 2011). Co-
expression of TNF-α+ and IFN-γ+ is observed within three to
four divisions, but extended proliferation leads to the loss of TNF-
α production for a substantial proportion of activated CD8+ T
cells leading to a progressive diminution inpolyfunctional capacity
(Denton et al., 2011). Importantly, the capacity of naïve, effector
and memory T cells to make IFN-γ and TNF-α is directly linked to
the presence of deﬁned epigenetic signatures within the proximal
promoters (Denton et al., 2011). For example, the tnfA proximal
promoter of naïve OT-I cells has an overall permissive epigenetic
landscape with increased chromatin accessibility, enrichment for
H3K4me3/H3K9ac and lack of H3K27me3. This is compared to
the generally repressive epigenetic signature for the ifnG promoter
with a closed chromatin structure, lack of H3K4me3/H3K9ac and
enrichment of H3K27me3 (Northrop et al., 2006; Denton et al.,
2011; Zediak et al., 2011).
The ifn-γ promoter region undergoes signiﬁcant remodeling
in effector CD8+ T cells, becoming more accessible and acquiring
a permissive epigenetic signature (Northrop et al., 2006; Den-
ton et al., 2011; Zediak et al., 2011). The fact that such events
are required for the acquisition of effector gene expression and
take time to eventuate probably explains the link between contin-
ued cell division and the acquisition of lineage-speciﬁc functional
capacity within recently activated T cells (Lawrence and Braciale,
2004; Jenkins et al., 2008; Denton et al., 2011). While extended
effector T cell differentiation leads to permissive epigenetic marks
being deposited within the ifn-γ promoter to allow IFN-γ expres-
sion (Northrop et al., 2006; Denton et al., 2011; Zediak et al.,
2011), there was progression to a more repressive tnfA epige-
netic signature (decreased chromatin accessibility and increased
H3K27me3 deposition; Denton et al., 2011). Importantly, the
fact that both activating and repressing chromatin remodeling
events were apparent at different loci, but within the same effec-
tor CTL effector population, suggests that opposing regulatory
mechanisms can act simultaneously at distinct gene loci.
EPIGENETIC AND THE MAINTENANCE OF EFFECTOR
FUNCTION WITHIN MEMORY T CELLS
A cardinal feature of memory T cells is their ability to elicit rapid
effector function upon antigen recognition without the need for
further differentiation. A number of studies have demonstrated
the ability to maintain this functional capacity in the resting state
is likely underpinned by maintenance of permissive epigenetic
signatures at key gene loci. For example, virus-speciﬁc memory
CD8+ T cells exhibit an open chromatin structure with enrich-
ment of H3K4me3, H3K9ac and loss of H3K27me3, at the ifnG,
tnfA, gzmB, and pfp effector gene loci (Northrop et al., 2006, 2008;
Araki et al., 2008, 2009; Denton et al., 2011; Zediak et al., 2011).
Importantly, maintenance of a permissive epigenetic signature
at the IFN-γ and TNF-α gene loci within virus-speciﬁc mem-
ory T cells coincided with docking of RNA polymerase II, a core
component of the transcriptional machinery, at the proximal pro-
moter (Denton et al., 2011; Zediak et al., 2011). This “stalling” of
RNA pol II at the transcriptional start site of proximal promot-
ers is associated with genes that are “poised” or “at the ready”
for transcriptional activity (Margaritis and Holstege, 2008). Thus,
epigenetic re-programing that results in maintenance of permis-
sive epigenetic signatures at key effector gene loci enables memory
T cells to keep RNA pol II “on-hold” at the TSS. Subsequent to
TCR ligation, the RNA polymerase is released, allowing rapid
gene expression and ensuring rapid memory T cell effector func-
tion (Figure 3). Interestingly, not all effector gene loci appear to
be “poised” in memory CD8+ T cells with RNA poll II docking
not observed at the gzmB, pfp (Zediak et al., 2011) or gzmA (L.
Hatton, B. E. Russ, and S. J. Turner, unpublished data) proxi-
mal promoters, despite the presence of a permissive epigenetic
signature. While gzmB and gzmA expression is up-regulated in
reactivated memory CD8+ T cells, it is delayed when compared to
cytokine production (Lawrence and Braciale, 2004; Jenkins et al.,
2007, 2008; Moffat et al., 2009; Denton et al., 2011; Zediak et al.,
2011). Thus, it appears that different molecular mechanisms work
FIGURE 3 | Epigenetic reprogramming within key loci of memoryT
cells enables rapid effector function upon restimulation. (A)Within
naive CTL, key effector gene loci, such as IFN-γ or gzmB, exhibit repressive
epigenetic signatures characterized by a heterochromatin structure,
deposition of H3K27me3, and lack of H3K4me3 and H3K9ac. UponT cell
activation, these gene loci undergo signiﬁcant chromatin remodeling
becoming more accessible and acquiring a permissive epigenetic signature
characterized by loss of H3K27me3, and deposition of H3K4me3 and
H3K9ac. This permissive signature acts as a platform allowing recruitment
of gene speciﬁc TFs and the transcriptional machinery needed to drive
transcription. (B) In memory cells, the permissive epigenetic signature at
effector gene loci is maintained in the long term. The maintenance of
permissive epigenetic signatures at key effector gene loci within memory T
cells serves to keep RNA pol II “on-hold” at theTSS. Subsequent to TCR
ligation, the RNA polymerase is released, allowing rapid gene expression
and thus, rapid memory T cell effector function.
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to impart different kinetics of cytokine versus cytolytic effector
gene expression within reactivated memory T cells.
A more recent study has utilized high-throughput sequenc-
ing in combination with ChIP to map genome-wide H3K4me3
and H3K27me3 deposition within polyclonal naïve and memory
human CD8+ T cell populations (Araki et al., 2009). In general
agreement with previous studies, a direct positive or negative
correlation between gene expression and respective H3K4me3 or
H3K27me3 deposition was observed (Araki et al., 2009). Interest-
ingly, this genome-wide analysis also identiﬁed other correlates of
gene transcriptional activity. For example, some loci within mem-
ory T cell populations exhibited H3K4me3 deposition, but only
active transcription upon anti-CD3 stimulation (termed poised
loci), a pattern not dissimilar to poised effector loci identiﬁed in
previous analyses of virus-speciﬁc memory CTL (Denton et al.,
2011; Zediak et al., 2011). Thus, epigenetic re-programing is a
likely mechanism that underpins both the acquisition of lineage-
speciﬁc T cell effector function and the rapid responsiveness that
exhibited by memory T cells. The Araki study also suggests that
different epigenetic signatures may be key in regulating different
types of transcriptional responses during T cell differentiation.
This is difﬁcult to fully ascertain due to the polyclonal nature of
the T cell populations analyzed. It will be of interest to examine
T cell populations that have a linked differentiation history (i.e.,
are known to be responding to the same differentiation signals).
Moreover, the T cell subsets examined in the Araki study were
static populations and thus, there is no insight into the dynamics
of epigenetic re-programing upon T cell activation. For example,
do such changes occur quickly upon activation and do they all
require cellular division?
SIGNALS THE DRIVE THE DYNAMIC CHANGES IN
EPIGENETIC SIGNATURES WITHIN ACTIVATED T CELLS
Interestingly, there are few studies that have identiﬁed the spe-
ciﬁc signals that shape the epigenetic re-programing of T cell
differentiation in response to activation. It is appreciated that the
provision of both co-stimulatory and cytokine signals at the time
of CTL activation promotes up-regulation of speciﬁc transcrip-
tional programs associated with full maturation of effector and
memory CD8+ T cell responses (Agarwal et al., 2009). In par-
ticular, the combination of IL-12 and IFN-α signaling promotes
up-regulation of effector genes such as gzmB, IFN-γ, and the
TFs, T-bet, and Eomes (Agarwal et al., 2009). Importantly, up-
regulation of signature CD8+ T cell effector genes in response to
these third signals is associated with chromatin remodeling and
an increase in histone acetylation within these effector and TF
gene loci (Agarwal et al., 2009). Thus, IL-12 and type I IFN signals
induced the appropriate chromatin remodeling events required to
promote increased transcriptional activity at those gene loci key
for both effector and memory T cell differentiation.
As mentioned earlier, provision of CD4+ T cell help is essential
for the establishment and maintenance of CD8+ T cell mem-
ory. Given the dynamic epigenetic remodeling that occurs with
memory T cell differentiation, CD4 help likely plays a key role
in establishing the appropriate permissive epigenetic signatures
within effector gene loci of memory T cells. This is supported by
the observation that memory virus-speciﬁc CD8+ T cells, gener-
ated in the absence of CD4+ T cell help, had diminished histone
acetylation at the ifnG gene, with this correlating with decreased
IFN-γ expression (Northrop et al., 2006, 2008). It will be of partic-
ular interest to determine the extent to which a lack of CD4+ T cell
help contributes to inappropriate epigenetic re-programing dur-
ing virus-speciﬁc memory T cell differentiation. Does such help
only result in remodeling of a limited number of gene loci, or are
there broader consequences? We are currently utilizing ChIP-seq
approaches to examine genome-wide changes in the epigenome
between“helped”and“unhelped”memory T cells to help pinpoint
both the precise mechanisms, and gene loci within virus-speciﬁc
T cells that undergo CD4-dependent epigenetic re-programing
upon activation.
Questions remain regardingwhat the precise enzymes and tran-
scription factors are that come to together to rewrite the epigenetic
signature during T cell differentiation. The answers to these ques-
tions will be important if such processes are ever to be targeted
for the optimization (in the case of vaccine strategies for example)
or the attenuation (in the case of autoimmune disease) of T cell
immunity. One thing that is clear is thatwith the recent advances in
systems biology approaches, our appreciation of just these molec-
ular mechanisms ﬁne tune our T cell immune responses can only
grow and will provide new opportunities to think about how to
best harness T cell immunity to ﬁght infection, treat cancer and
ameliorate autoimmune disease.
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